Trials / Unknown
UnknownNCT03955016
Rehabilitation for Patients With Pulmonary Hypertension
A Randomized Controlled Trial to Evaluate the Effect of a Rehabilitation Program on the Exercise Capacity of Patients With Pulmonary Hypertension
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- KU Leuven · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the impact of a personalized, partly supervised rehabilitation program on the exercise capacity in patients with pulmonary hypertension. The rehabilitation program consists of 2 weeks inpatient, 2 weeks ambulatory and 11 weeks home based rehabilitation.
Detailed description
The present study is a 15 weeks, randomized (1:1) controlled trial. Patients in both groups will not change their usual medical treatment. After 2 clinical visits (screening and randomization visit), patients in the intervention group will follow a 15 week rehabilitation program consisting of 2 weeks inpatient, 2 weeks outpatient and 11 weeks home based rehabilitation. At the end of the outpatient rehabilitation phase (week 4) and the home-based program (week 15), clinical outcomes will be reassessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pulmonary rehabilitation | Rehabilitation program consisting of 2 weeks inpatient (supervised training 5 times per week), 2 weeks outpatient (supervised sessions 3 times per week) and 11 weeks home-based exercise training (weekly phone call). During the inpatient phase, patients will receive on top of the supervised training sessions a consultation of the dietitian, PH psychologist, social worker and specialized nurse. During the ambulatory rehabilitation phase patients will have 2 session with the occupational therapist. Every supervised training session contains: 1. Interval training on a cyclo-ergometer 2. Strength training of the upper and lower extremities 3. Guided walks |
Timeline
- Start date
- 2018-11-13
- Primary completion
- 2020-11-01
- Completion
- 2020-11-01
- First posted
- 2019-05-17
- Last updated
- 2019-10-10
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03955016. Inclusion in this directory is not an endorsement.